JENNY SOUTHWOOD: Open Payments
NPI 1528449816 · MADISON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,310 in 172 payments from 23 companies in 2025. Trend: 2023 $725 · 2024 $889 · 2025 $3,310
Food & beverage: $3,211Education: $99
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 25 | $478 |
| Novo Nordisk Inc | 27 | $424 |
| Astellas Pharma US Inc | 14 | $286 |
| AstraZeneca Pharmaceuticals LP | 13 | $280 |
| PFIZER INC. | 10 | $178 |
| Amgen Inc. | 3 | $160 |
| Lilly USA, LLC | 8 | $160 |
| Lundbeck LLC | 9 | $155 |
| Inspire Medical Systems, Inc. | 1 | $147 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $126 |
Products named: REXULTI, Wegovy, AIRSUPRA, Veozah, INSPIRE, MOUNJARO, TRINTELLIX, NURTEC ODT.
Industry payments across AL — which companies pay providers there.
